History

2020

  • 06Received Orphan Drug Designation from FDA for NT-I7 in the treatment of Progressive Multifocal Leukoencephalopathy
  • 04Announced a clinical collaboration with Bristol Myers Squibb (BMS) for NT-I7/Nivolumab combinations

2019

  • 08NeoImmuneTech Co., Ltd., a wholly owned subsidiary of NIT, was established in Aug 2019 (and the liaison office in Korea was subsequently closed out in October 2019)
  • 04Received Orphan Drug Designation from FDA for NT-I7 in the treatment of Idiopathic CD4 lymphocytopenia
  • 01First U.S. Glioblastoma (non-lymphopenia) Patient Treatment with NT-I7 in Phase 1b/2a study
    Received Phase 1b/2a IND Approval from FDA for NT-I7 and TECENTRIQ® (Roche) targeting Advanced High-Risk Skin Cancers

2018

  • 12 First U.S. Glioblastoma (lymphopenia) Patient Treatment with NT-I7 in Phase 1b/2a study
    Received Phase 1b/2a IND Approval from MFDS for NT-I7 and KEYTRUDA® (Merck) targeting Triple Negative Breast Cancers (TNBC)
  • 11 Received FDA IND Approval for Treatment of NT-I7 targeting Glioblastoma (non-lymphopenia) for Phase 1b/2a
  • 07 Announced Clinical Trial Collaboration with Merck and Genexine for NT-I7 and KEYTRUDA® (Merck) targeting
    Triple Negative Brest Cancer (TNBC)
  • 05 Announced Clinical Trial Collaboration of NT-I7 and TECENTRIQ® (Roche) targeting Advanced High-Risk
    Skin Cancers
    Established liaison office in Korea (670, Daewangpangyo-ro, Bundang-gu, Uspace2 B 501-1 Seongnam-si, Gyeonggi-do, Republic of Korea 13494)
  • 03 Received Phase 1b/2a IND Approval from FDA for NT-I7 targeting Glioblastoma (lymphopenia)

2017

  • 10Headquarters Relocated and Expanded to 2400 Research Boulevard, Rockville, MD 20850
  • 05Received Orphan Drug Designation from EMA for NT-I7 in the treatment of Idiopathic CD4 lymphocytopenia

2015

  • 06Received development and commercialization rights of NT-I7 (efineptakin alfa, rhIL-7-hyFc) from Genexine in America and Europe

2014

  • 10Headquarters Relocated to 2200 Research Blvd., Rockville, MD 20850.
  • 01NeoImmuneTech, Inc. Founded at 20271 Goldenrod Lane Germantown, MD 20876